Regenerative Medicine & Cell Therapy

Pioneering MUSE Stem Cells, Exosomes and Longevity therapies for regenerative medicine.

Product Portfolio

Comprehensive range of live-cell and cell-free therapies across regenerative medicine, immunotherapy, and longevity.

MUSE Stem Cells

Wharton's Jelly, Cord Blood, Bone Marrow, Peripheral Blood, Adipose (SVF) — Autologous & Allogeneic

Telomere Extension

Longevity therapy targeting telomere length for anti-aging


MUSE Exosomes

Stem Cell-derived. Antigen FREE, high purity

Products' Applications

Brain & CNS

MS, ALS, PSP, Stroke, Dementia, Alzheimer's, Essential Tremor — via Intrathecal or IV

Organ Repair

Kidney, heart, liver, lung, spleen, micro-vessel, eye — regeneration and repair

Orthopedics

OA, Sports Injuries, Osteoporosis, AVN, Spinal Facet Joints, DMD

Anti-viral

Hep-B/C, HPV, MRSA, HIV

Rebuild Blood Vessels

Multiple Sclerosis — Before & After

Exosomes

MUSE Exosomes —
Essence of Stem Cells

Exosomes are small extracellular vesicles (EV) secreted from mesenchymal stem cells (MSCs). They contain bioactive molecules such as proteins and miRNA, enabling cell-to-cell communication that stimulates healing and recovery. At only 100 nm, exosomes penetrate the skin and blood-brain barrier, delivering strong regenerative capacity.

MUSE Exosomes:

Products & Applications

IV Infusion (200 FU)

For nervous system damage, stroke, dementia, essential tremors, and wellness.

Meso / Intra-articular
(10–20 FU)

Targeted local delivery for joint and tissue applications.

Shelf-life & Storage

  • 12 months, dry form at room temperature
  • 18 months, dry form at 4°C
  • 30 days, hydrated at 4°C

Applications

  • Wellness & Anti-Aging
  • Wound Healing
  • Skin brightening
  • Back and joint pain

Secretomes vs. Exosomes:

Why Purity Matters

MUSE Exosomes Hydrogel —
Topical Skin Therapy

Apply hydrogel all over face with fingertips and rub gently.

Treats

  • Acne Scarring & Fine lines/wrinkles
  • Age spots & Uneven skin tone
  • Sagging skin & Sun damage
  • Skin irritation & Redness

Severe Skin Allergy & Psoriasis

Significant improvement after 1 week using 20FU Exosomes HydroGel (trans-cellular, trans-dermal, anti-inflammatory, tissue regeneration)

MUSE Exosome Applications

Cross Blood-Brain Barrier

Alzheimer's, Stroke, Autism, Essential Tremors, Dementia

Penetrate Through Skin

Hair loss, Skin rejuvenation, Wound healing, Psoriasis, Severe Skin Allergy, Aging Pigmentation

Chronic Diseases

Diabetic retinopathy, Chronic/acute kidney failure, Diabetic cardiomyopathy,
Dry Eyes

MUSE Exosome Eye Drops & Nebulizer

MUSE Exosome Eye Drops

Exosomes (100nm) penetrate the cornea barrier (400nm) to reach the retina, macula, and optic nerve — replacing invasive injections and laser. Proven to alleviate dry eye symptoms.

MUSE Exosome Nebulizer

Delivers 100nm exosomes via nasal pathway through trigeminal nerves or blood-brain barrier. Treats ALS, MS, Alzheimer's, Parkinson's, Cerebral Palsy, Asthma, Stroke, and more. Portable and safe for children.

Stem Cells

What Are MUSE Stem Cells?

Stem cells are the body's master cells — capable of differentiating into muscles, bones, cartilage, brain, nervous system, blood, and more. They trigger regeneration and repair during wound healing and disease recovery. Stem cell stores naturally decline with age, making replenishment critical for health.

100%

Baby

Peak stem cell activity

40%

Age 18

Significant decline begins

25%

Age 30

Further reduction

5%

Age 60+

Near depletion

Conditions Treated with
MUSE Stem Cells

Autoimmune Diseases

Diabetes Type-1, Multiple Sclerosis, Lupus (SLE), Rheumatoid Arthritis

Age-Related & Degenerative

Back Pain (Degenerative Disc), Parkinson's Disease, Kidney Disease

Diabetes Complications

Diabetic Foot Ulcer, Neuropathy, Erectile Dysfunction, Retinopathy, Cardiomyopathy, Kidney Disease

Musculoskeletal

Sports Injury, Joint Pain, Avascular Necrosis (AVN), Spinal Cord Injury, Sickle Cell Anemia

Case Study

MUSE Stem Cells for
Diabetic Complications

Diabetes causes cascading damage across multiple organ systems. Stem cells and exosomes address root causes — regenerating blood vessels, nerves, and organs.

Retinopathy

Stem cells repair retinal blood vessels, preventing blindness

Diabetic Foot Ulcer

New blood vessel growth prevents amputation

Neuropathy

Nerve regeneration restores sensation and reduces pain

Kidney Failure

Normalizes kidney function over 4–6 months

Patient Story

Type 2 Diabetes:
Madam Savorn's Story

Madam Savorn, 72, a retired WHO medical doctor, had lifelong diabetes. Despite diet control, she could not manage blood sugar without medication.

"Before stem cell therapy, I took 3 pills (3000 mg/day). Now I only take one-third of a pill (300 mg/day) to maintain normal blood sugar."

Tablets reduced from 3/day → 1/day over 3 weeks post-treatment.

Case Studies

Chronic Kidney Disease —
Patient Outcomes

Stem cells and exosomes normalize kidney function over 4–6 months. Four documented cases demonstrate measurable improvement in creatinine and eGFR levels.

Patient 1 — Malaysian, 29F

Diabetes Type-I, Retinopathy, CKD.
After 2 doses of 200FU: Creatinine 275→195 mmol/L; eGFR 19→29

Patient 2 — Malaysian, 83M

End-stage kidney failure. Began urinating 4 days post-exosome infusion. 5kg edema reduction; cellulitis cleared.

Patient 3 — Omani, 63M

18 years diabetic. Creatinine normalized: 1.23 → 1.00 mg/dl after treatment.

Patient 4 — Malaysian, 64M

25 years diabetic. Creatinine normalized: 1.80 → 1.17 mg/dl after treatment.

Diabetic Foot Ulcers — Angiogenesis

Before & After Stem Cell Treatment

The Challenge

Conventional treatment — dressings, antibiotics, hyperbaric therapy — cannot regenerate damaged blood vessels causing peripheral arterial insufficiency.

The Solution

Stem cells rapidly regenerate new arterial/blood networks, facilitating recovery of diabetic ischemia wounds. New collateral vessels visible at 6 months via angiogram.

Back Pain, Degenerative Disc & Sports Medicine

Stem cells rehydrate and rebuild degenerative discs —
25% growth every 3 months.

Sports Injuries Treated

  • Type-2 Hyaline Cartilage & ACL/PCL
  • Avascular Necrosis (AVN)
  • Tendon & Keloid-Free Muscle Repair
  • Increased Bone Density
  • Anti-inflammation & Accelerated Recovery

Osteoarthritis (OA) — Case: Madam Fatemah, 78

Kuwaiti female with OA Stage-4 chose Stem Cell Therapy over Total Knee Replacement. Result: diabetes controlled (HbA1c <7), knee pain disappeared in 3 weeks, bone density improved. Immediate pain-free walking — no rehabilitation needed.

Neurological Conditions:
MS, Parkinson's & Stroke

Multiple Sclerosis

36-year-old Arab female: lost ability to walk. After stem cell treatment — walks for hours pain-free. MRI shows significant reduction of brain lesions at 3 months.

Parkinson's Disease

62-year-old female, wheelchair-bound since 2007. After stem cell treatment: all tremors stopped, regained fine motor skills, walks 2–3 hours daily, resumed full-time work. All 8 quality-of-life scores doubled.

Stroke

Stem cells produce new blood vessels (angiogenesis) to bypass blocked vessels, preserving brain function. New cerebral vessels visible from (A)→(E) over 6 months.

Pulmonary Fibrosis, Cardiomyopathy & Spinal Cord

Idiopathic Pulmonary Fibrosis

77-year-old male, oxygen-dependent. After stem cell therapy: blood oxygen rose from 47% → 85% over 5 months. No longer dependent on oxygenator.

Dilated Cardiomyopathy

Dr. Mohammed Osama, Qatar: Ejection Fraction improved from 22% → 45% (normal: 55–65%) within 12 months of 200M stem cell therapy.

Complete Spinal Cord Detachment

Kang Ai Liew, 26F: C4 detachment from car accident. After Stem Cells + Exosomes — sensation restored in hands, arms, chest; finger motor movement returning.

Neck Injury / Degenerative Disc

Mr. Sok Seila, Cambodia: C4-C6 degeneration, osteophyte formation. 4 weeks post-treatment — significant pain score decrease; ongoing improvement.

DMD, Cerebral Palsy, Autism & Coma

Duchenne Muscular Dystrophy (DMD)

Stem cells repair and regenerate muscle loss (monthly infusion required). Patients gain muscle mass. Exosomes improve intellectual disability.

Cerebral Palsy

Stem cells repair brain cells in patients aged 2–6. Results: normal motor movement, accelerated growth, improved immune system.

Autism Spectrum Disorders

Stem cells repair damaged tissue, regulate immune imbalance, reduce pro-inflammatory cytokines. Patients improve in communication, social relationships, and behavior.

Comatose / Vegetative State

Emirati female, 36, in coma 4 years. Treatment: 200FU exosomes/week for 6 weeks IV. Result: regained consciousness, communicates via eye movements, gained weight.

Sickle Cell Anemia —
Saif's Story

Saif, 27 — diagnosed with SCA 2014. Morphine drips, oxygen, blood transfusions. Stopped medication 2015 seeking alternatives.

"The weekly crisis events stopped. I can now walk and shop for hours with my sister. I am pain-free 5 years after treatment."


Stem Cell Treatment Outcomes

  • Builds new blood vessels, bypassing blockages
  • Minimizes or eliminates crisis events
  • Reduces joint damage (AVN)
  • 90% success rate
  • Effectiveness lasts 5–10 years
Longevity

Longevity Research —
Telomere Extension

Aging is linked to telomere shortening and age-related disease. Anti-Aging therapy investigates the effect of treatment on telomere length extension — targeting longevity at the cellular level.

Infertility Treatment

Stem Cell + Exosome therapy improved sperm count and penile function in a 30-year-old azoospermia patient. Total sperm count reached 50,000 sperm/mL after treatment.

Research & Publications

Research Publications &
Clinical Trials

Key Publications

Pharmaceuticals (2022) — hUC-MSC Small Extracellular Vesicles ameliorate insulin resistance in Type-2 Diabetes rats

Regenerative Therapy (2022) — Safety study of allogeneic MSC therapy in animal mode

World Scientific — MSC for treatment of immune-mediated diseases

Active Clinical Trials (Phase I & II)

  • Exosomes for Cardiomyopathy (Heart)
  • MSC & Exosomes for CKD & Diabetic Complications
  • Autologous BMSC Chondrocytes for Osteoarthritis

Pre-Clinical Trials

  • Allogeneic MSC & Exosomes for Diabetic Complications
  • Allogeneic MSC for Osteoarthritis (sheep model)
  • Exosomes from hESC/iPSC for Chronic Kidney Disease

Export Packages

Products are exported globally with specialized logistics and storage solutions to maintain viability.